More people entered the labor force, and not all were able to find jobs right away. Bad weather may have been a factor
Consumers like curation—stories that narrow the choices down to the best two or three
With yet another tweak to the health-care law, the Obama administration is heading off a popular Republican attack
Music executives are tapping services such as Shazam and Spotify to help predict tomorrow’s next big hits
In the five years since the most recent bottom, the stock market has very nearly tripled
Arunachalam Muruganantham, aka "Menstrual Man," designed simple devices that allow rural Indian women to make their own sanitary pads
The company's dubbing of storms with Greek and Latin names began in 2012 to help 'personalize' extreme weather
European MBA programs compete with top-tier U.S. schools for the best students at home and abroad
Organizations offer special training for senior entrepreneurs
Founders: Dr. Daniel J. Abrams; Tom Anchordoquy, PhD; and Karen Stevens, PhD
VC Investment over the last four quarters: $21.5 million
Founded in 2005, this seven-person biopharmaceutical company develops drugs for the treatment of severe central nervous system diseases. In addition to VC funding, Sierra received about $230,000 in grants from the State of Colorado, the University of Colorado, and the Coleman Institute. As for the recession, its founders say the company will be keeping close tabs on the funding and partnership environment over the next two to three years, despite already being funded for drug development work for the next three years.
Key to startup success: "Be persistent in the development of your data and business model to enable you to create a financial model that has a high likelihood of helping patients and therefore is fundable by the investor community."